- Report
- September 2020
- 76 Pages
Global
From €3995EUR$4,450USD£3,402GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4444EUR$4,950USD£3,785GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4444EUR$4,950USD£3,785GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4444EUR$4,950USD£3,785GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4444EUR$4,950USD£3,785GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4444EUR$4,950USD£3,785GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4444EUR$4,950USD£3,785GBP
- Report
- September 2022
- 115 Pages
Global
From €6734EUR$7,500USD£5,735GBP
- Report
- September 2022
- 62 Pages
Global
From €3547EUR$3,950USD£3,020GBP
- Report
- January 2022
- 60 Pages
Global
From €3547EUR$3,950USD£3,020GBP
- Report
- January 2022
- 60 Pages
Global
From €3547EUR$3,950USD£3,020GBP
- Report
- May 2024
- 180 Pages
Global
From €2245EUR$2,500USD£1,912GBP
- Report
- January 2024
- 167 Pages
Global
From €2245EUR$2,500USD£1,912GBP
- Report
- January 2024
- 171 Pages
Global
From €2245EUR$2,500USD£1,912GBP
- Report
- October 2023
- 162 Pages
Global
From €2245EUR$2,500USD£1,912GBP
- Report
- August 2023
- 102 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- June 2024
- 206 Pages
Global
From €7138EUR$7,950USD£6,079GBP
- Report
- June 2024
- 200 Pages
Global
From €7138EUR$7,950USD£6,079GBP
- Report
- June 2024
- 200 Pages
Global
From €7138EUR$7,950USD£6,079GBP
- Report
- June 2024
- 200 Pages
Global
From €7138EUR$7,950USD£6,079GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more